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Toward a Better Understanding of...
Towards Discovering Inhibitors of  cyt c 
Biosynthesis in Systems I, II, and III
Shannon J. Jiang
Mentor: Robert Kranz
Cytochrome c (cyt c) is a heme protein found in most organisms (including human 
pathogens) that plays an essential role in both aerobic and anaerobic growth. The 
biogenesis of c-type cytochromes occurs by three different systems (Systems I and II in 
bacteria and System III in humans). Besides requiring different protein systems, their 
site of synthesis is also different. Systems I and II function in the periplasmic space while 
System III functions in the mitochondrial inter-membrane space. These differences may 
allow for selective targeting of bacterial systems using antimicrobial compounds which 
may be beneficial in combating infectious bacterial diseases. My goal is to develop a 
robust assay that detects cyt c maturation quantitatively to allow for subsequent analyses 
of levels of cyt c maturation in the presence and absence of potential inhibitors. In 
recombinant E. coli, Systems I and II produce cyt c in the periplasm while System III 
makes cyt c in the cytoplasm. An in vivo assay has been developed in the Kranz lab that 
detects cyt c produced in the periplasm, but cannot detect production in the cytoplasm. 
Therefore, I have been optimizing an in vitro method to extract cyt c from recombinant 
E. coli grown in small volumes (<5mL) and detect it quantitatively by heme stain. Here 
I present work showing that the in vitro assay can detect differences in the amount of cyt 
c produced within System III. I also explored the optimal conditions for comparing cyt 
c biogenesis across the three systems in recombinant E. coli. Future direction is to test 
known inhibitors of heme biosynthesis and protein biosynthesis to test the effectiveness 
of this assay.
